Revenue

Accord Healthcare's launch of generic lenalidomide signals a new era of affordability for a key cancer drug, intensifying competition and lowering costs.

Camping app The Dyrt is giving away $500,000 in PRO subscriptions. A look at the high-stakes strategy to capture the booming RV market.

As KP Tissue prepares to release Q4 2025 results, all eyes are on Kruger Products' performance after a year of major strategic investments and expansion.

As AI 'hallucinations' cost firms billions, one company claims a breakthrough with 99%+ factual accuracy. But can it bridge the AI trust gap?

First-ever bedrock drilling at Copeçal West validates a 6km surface anomaly, hinting at a large-scale gold deposit in a historically rich mining region.

Hammond Power Solutions' C$365M acquisition of AEG Power Solutions transforms the transformer maker into a global force in industrial power electronics.

A partnership between NSA Labs and Proscia is slashing study times for brain research, showing how digital platforms are key to finding new therapies faster.

A major patent deal shields Esperion's flagship drugs from generics, securing future revenue but delaying cheaper options for millions of patients.

For the 5th year, Mindr proves family-first policies aren't just good ethics—they're a powerful strategy for talent, retention, and bottom-line growth.

As creators face relentless pressure, RHEI's Made platform launches AI agents to automate video production and protect IP, reshaping the creator economy.

With a new rotator cuff device and enhanced meniscal repair system, Arcuro Medical is challenging orthopedic giants with its innovative all-suture technology.

Fathom Realty appoints 39-year veteran Stephanie Verderose to a new growth VP role, signaling a strategic focus on agent success in a volatile market.

Beyond insurance, Superior HealthPlan invested nearly $1.2 million in 2025, opening a Uvalde health center and tackling youth mental health across Texas.

Eagle Point Credit Co. slashes its dividend after reporting major losses but counters with a $100M buyback and a strategic shift beyond CLO equity.

Sifted's new agentic AI platform acts as an 'always-on analyst,' promising to slash shipping costs and complexity by making autonomous, data-driven moves.

Annexon Biosciences spotlights its novel C1q inhibitor, Vonaprument, aiming to be the first therapy to preserve vision in geographic atrophy patients.

In a strategic move to restore trust in digital health, HealthCentral has acquired an AI platform that vets and activates physician influencers.

Pangaea Logistics declared a $0.05 dividend, but what does this move signal about the company's health and the broader dry bulk market's future?

Facing a tech shortage & vehicle complexity, Autoshop Answers launches a national virtual training series to arm repair shops with critical new skills.

Partnering with Riskified, the travel platform boosted approvals to 93%, enabling expansion and enhancing customer experience in a high-fraud region.